Medicomunicare Magazine | Health and Medical News
Immunotherapy has dramatically improved outcomes for some types of cancer. But prostate cancers are typically immune cold, which means these patients have benefited little from immunotherapies. Finding a way to rev up the immune response would create tremendous opportunity to improve patient outcomes. Researchers led by the University of Michigan Rogel Cancer Center started with
Read More